Stakeholder engagement is a foundation of our approach to sustainability, and we have identified our key stakeholders as patient groups, employees, investors, regulators, suppliers, government, healthcare professionals, plasma donors, business partners and the academic and scientific community. Learn More about Our Engagement
Our sustainability focus areas are further guided by our material topics, which guide continuous improvement across our operations and transparency in areas that matter most to our key stakeholders.
CSL’s Executive Sustainability Committee has overall responsibility for the materiality process and executes a global materiality assessment on a biennial basis. In 2021/22, we concluded our fifth assessment and followed the Global Reporting Initiative (GRI) standards of sustainability context, materiality, completeness and stakeholder inclusiveness through our process of identification, review and prioritisation. Learn More About Our Material Topics
Our Purpose and Values form the foundation of CSL's global commitment to sustainability. Our Code of Responsible Business Practice further guides and shapes the way we do business. It defines our ethical standards and sets out our commitment to sustainable development.
Sustainability is governed by CSL's Executive Sustainability Committee. The Committee facilitates the development of our sustainability targets and drives awareness, integration and continuous improvement throughout the Company. The Committee reports to the CEO/ Managing Director and is further supported by the Board's committees.
View Our Code of Responsible Business Practice